Prelude Therapeutics Inc - PRLD - stock price prediction, stock price target, analyst ratings from 4 analysts

Prelude Therapeutics Inc has a share price target of US$ 8, revenue growth forecast of 124.9%, and profit growth estimate of 62.1% for FY26, based on top 4 analyst calls.